What question did this study set out to answer?

To determine if switching from aspirin to another antithrombotic regimen reduces the recurrence of ischemic stroke.

April 10, 2026

After ischemic stroke in patients receiving aspirin, switching to another antithrombotic regimen does not reduce recurrence

Key Result

Switching to another antithrombotic regimen after an ischemic stroke in patients already receiving aspirin does not reduce the risk of recurrence.

Key Points

To determine if switching from aspirin to another antithrombotic regimen reduces the recurrence of ischemic stroke.
Observational analysis of ischemic stroke patients
Comparison of antithrombotic regimens
Assessment of recurrence rates
No significant reduction in stroke recurrence after switching regimens
Stable recurrence rates observed among patients on aspirin
Implications for antithrombotic management following ischemic stroke

Abstract

GIM/FP/GP:Formula: see text Neurology:Formula: see text Hematology:Formula: see text.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Cite this study

Shaik et al. (Mon,) reported a other. Switching to another antithrombotic regimen after an ischemic stroke in patients already receiving aspirin does not reduce the risk of recurrence.

www.synapsesocial.com/papers/69d892d16c1944d70ce040ec — DOI: https://doi.org/10.7326/annals-26-00772-jc

Authors

Hajeera Shaik

Dinesh Jillella

Journals

Annals of Internal Medicine

Actions

Institutions

Grady Memorial Hospital

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

After ischemic stroke in patients receiving aspirin, switching to another antithrombotic regimen does not reduce recurrence

Key Result

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Cite this study

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion